470 related articles for article (PubMed ID: 32991310)
1. Pharmacological agents and natural compounds: available treatments for osteoporosis.
Martiniakova M; Babikova M; Omelka R
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
4. One year in review 2018: progress in osteoporosis treatment.
Figliomeni A; Signorini V; Mazzantini M
Clin Exp Rheumatol; 2018; 36(6):948-958. PubMed ID: 30526765
[TBL] [Abstract][Full Text] [Related]
5. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
6. New understanding and treatments for osteoporosis.
Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
[TBL] [Abstract][Full Text] [Related]
7. Targeting WNT signaling in the treatment of osteoporosis.
Baron R; Gori F
Curr Opin Pharmacol; 2018 Jun; 40():134-141. PubMed ID: 29753194
[TBL] [Abstract][Full Text] [Related]
8. Denosumab in the treatment of glucocorticoid-induced osteoporosis.
Coskun Benlidayi I
Rheumatol Int; 2018 Nov; 38(11):1975-1984. PubMed ID: 30019224
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic targets for osteoporosis.
Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
[TBL] [Abstract][Full Text] [Related]
10. Emerging anabolic treatments in osteoporosis.
Mosekilde L; Tørring O; Rejnmark L
Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
[TBL] [Abstract][Full Text] [Related]
11. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Shiraki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
[No Abstract] [Full Text] [Related]
12. Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
Suzuki A; Sekiguchi S; Asano S; Itoh M
J Pharmacol Sci; 2008 Apr; 106(4):530-5. PubMed ID: 18431035
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
14. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
15. Potential anti-catabolic and anabolic properties of strontium ranelate.
Mentaverri R; Brazier M; Kamel S; Fardellone P
Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
[TBL] [Abstract][Full Text] [Related]
16. Anti-resorptives in the management of osteoporosis.
Miller PD
Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):849-68. PubMed ID: 19028360
[TBL] [Abstract][Full Text] [Related]
17. Osteoanabolic and dual action drugs.
Tabacco G; Bilezikian JP
Br J Clin Pharmacol; 2019 Jun; 85(6):1084-1094. PubMed ID: 30218587
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary osteoporosis in men.
Giusti A; Bianchi G
Clin Interv Aging; 2015; 10():105-15. PubMed ID: 25565793
[TBL] [Abstract][Full Text] [Related]
19. Anti-osteoporotic drugs and vascular calcification: the bidirectional calcium traffic.
Yavropoulou MP; Pikilidou M; Yovos JG
J Vasc Res; 2014; 51(1):37-49. PubMed ID: 24280985
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
Schacht E; Richy F; Reginster JY
J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]